China ETFs’ Paradox: Winning But Ignored in 2025

It’s been a good year for international equity ETFs. As a category, broad exposure funds tapping into both developed and emerging market equities have delivered outsized gains relative to U.S. markets this year, as well as much sought portfolio diversification.

Consider two popular ETF examples. The iShares Core MSCI Emerging Markets ETF (IEMG) and the Vanguard FTSE Europe ETF (VGK) have both outpaced the SPDR S&P 500 (SPY) in 2025. One of them has delivered more than twice the results of SPY, as seen in table below.

RETURNS

Source: VettaFi PRO

Investors have taken notice. IEMG has picked up more than $11.4 billion in fresh net assets this year. Meanwhile, VGK has seen $6.2 billion in net inflows. Other broad-based international equity ETFs benefiting from this momentum include:

What’s been interesting to note, however, is that appetite for international equity exposure and diversification has largely stayed top level. It hasn’t spilled much into single country opportunities. Case in point: China.

Broad-based China ETFs out of Favor

China has made a lot of headlines this year. From trade and tariff disputes with the U.S. to concerns about economic momentum to uncertainty as a new Five Year Plan takes shape for 2026, China has been at the center of a lot of noise.

And yet, China equities have been delivering strong results, outpacing U.S. markets notably in 2025.

According to Jeff Weniger, head of equity strategy at WisdomTree, China has been standing out all year, but no one seems to really care. In fact, he calls China an “amazing contrarian” opportunity for investors ready to buck the noise. WisdomTree is behind the WisdomTree China ex-State Owned Enterprises Fund (CXSE).